Optavia Parent Medifast Fourth Quarter Revenue Falls 38 Percent as Coach Count Drops 34 Percent
BALTIMORE, February 18, 2025 --
Medifast, parent of Optavia, reported fourth-quarter 2024 revenue of 119.0 million dollars, down 37.7 percent from 191.0 million dollars a year earlier, as the number of active earning Optavia coaches fell 34.1 percent to 27,100 and revenue per coach declined 5.5 percent to 4,391 dollars amid continued pressure on customer acquisition.
Net income was 0.8 million dollars, or 0.07 dollars per diluted share, compared with 6.0 million dollars, or 0.55 dollars, a year earlier. Chairman and Chief Executive Dan Chard said the company's top priorities are restoring growth by improving coach productivity through faster customer acquisition and expanding the number of active coaches, including customers using or coming off GLP-1 medications.
Medifast forecast first-quarter 2025 revenue of 100 million to 120 million dollars and earnings ranging from a loss of 0.50 dollars per share to breakeven. It ended the year with 162.3 million dollars in cash, cash equivalents and investment securities and no debt.
More Optavia news
Optavia Hit With California Class Action Over Optavia Premier Auto Renewals
Two customers have filed a proposed class action against Optavia LLC in San Diego County Superior Court alleging the company's Optavia Premier subscription program uses deceptive...
Medifast Q3 Revenue Falls 19.4% to $72 Million as Active Optavia/Trilivy Coaches Drop 48% to 10,200
BALTIMORE, Maryland - October 26, 2026 Medifast, Inc., the publicly traded parent of the coach-based nutrition business formerly marketed as Optavia and rebranded as Trilivy in...
Optavia Parent Reports Second Quarter Revenue of 76.4 Million Dollars
BALTIMORE, Md. -- August 3, 2026 Medifast reported second-quarter 2026 revenue of 76.4 million dollars for its Optavia business, with revenue per active earning coach of 6,529...
Optavia Parent Rebrands Lifestyle Brand as Trilivy Metabolic Health System
BALTIMORE, Md. -- July 17, 2026 Medifast said it is rebranding OPTAVIA, its lifestyle brand and wholly owned subsidiary, as Trilivy, describing the new identity as a...
Medifast Appoints Nicholas Johnson CEO Effective June 1 as Dan Chard Becomes Chairman
BALTIMORE, Md. -- May 26, 2026 Medifast said its board has appointed President Nicholas Johnson as chief executive officer effective June 1, 2026, completing the succession plan...